Latest Health News

Category: Latest News

  • Mylan to pay $465 mn over EpiPen overcharges to Medicaid

    —

    by

    elegant
    in

    Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday. The settlement with the Department of Justice and some other regulators resolves questions about Mylan's classification of EpiPen as a generic drug, the drugmaker said. Mylan said it…

  • Mylan to pay $465 mn over EpiPen overcharges to Medicaid

    —

    by

    creative
    in

    Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday. The settlement with the Department of Justice and some other regulators resolves questions about Mylan's classification of EpiPen as a generic drug, the drugmaker said. Mylan said it…

  • Hurricane Matthew death toll passes 800 in Haiti, cholera takes lives

    —

    by

    publisher
    in

    By Makini Brice and Joseph Guyler Delva CHANTAL, Haiti/PORT-AU-PRINCE (Reuters) – Hurricane Matthew's trail of destruction in Haiti stunned those emerging from the aftermath on Friday, with the number of dead soaring to 842, tens of thousands homeless and outbreaks of cholera already claiming more lives. Information trickled in from remote areas that were cut…

  • Hurricane Matthew death toll passes 800 in Haiti, cholera takes lives

    —

    by

    admin
    in

    By Makini Brice and Joseph Guyler Delva CHANTAL, Haiti/PORT-AU-PRINCE (Reuters) – Hurricane Matthew's trail of destruction in Haiti stunned those emerging from the aftermath on Friday, with the number of dead soaring to 842, tens of thousands homeless and outbreaks of cholera already claiming more lives. Information trickled in from remote areas that were cut…

  • Mylan pays $465 million to settle EpiPen Medicaid rebate dispute

    —

    by

    contributor
    in

    (Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…

  • Mylan pays $465 million to settle EpiPen Medicaid rebate dispute

    —

    by

    contributor
    in

    (Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…

  • Little evidence that antibiotics help open surgical wounds heal

    —

    by

    elegant
    in

    By Kathryn Doyle (Reuters Health) – There are no high-quality trials assessing whether using antibiotics or antiseptics on open surgical wounds speeds healing by slowing the growth of dangerous microorganisms, according to a new Cochrane review. While most surgical incisions are closed with stitches or staples, some cannot be closed if skin edges do not…

  • Little evidence that antibiotics help open surgical wounds heal

    —

    by

    contributor
    in

    By Kathryn Doyle (Reuters Health) – There are no high-quality trials assessing whether using antibiotics or antiseptics on open surgical wounds speeds healing by slowing the growth of dangerous microorganisms, according to a new Cochrane review. While most surgical incisions are closed with stitches or staples, some cannot be closed if skin edges do not…

  • ICU Medical to buy Pfizer’s infusion therapy business

    —

    by

    elegant
    in

    (Reuters) – Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about…

  • ICU Medical to buy Pfizer’s infusion therapy business

    —

    by

    elegant
    in

    (Reuters) – Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about…